Utah Retirement Systems Karuna Therapeutics, Inc. Transaction History

Utah Retirement Systems

  • $8.31 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$161.01 - $317.85 $688,478 - $1.36 Million
-4,276 Reduced 68.13%
2,000 $633,000
Q2 2023

Aug 14, 2023
BUY
$176.32 - $240.22 $170,854 - $232,773
969 Added 18.26%
6,276 $1.36 Million
Q1 2023

May 15, 2023
BUY
$161.33 - $204.36 $856,178 - $1.08 Million
5,307 New
5,307 $963,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email